Here, we demonstrate that the IBD risk SNP rs1893217 in PTPN2 is associated with increased expression of ACE2 and SARS-CoV-2 entry and might represent a novel COVID-19 genetic susceptibility biomarker. The gene discussed is ACE2; the disease is inflammatory bowel disease.